Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

219.4100 USD 5.0500 2.36%

As of 20:04:02 ET on 03/27/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 215.6700 High - Low: 220.4700 - 215.5100 Primary Exchange: NYSE Arca
Volume: 793,920 52-Week Range: 115.3117 - 244.9800 Beta vs SPSIBITR: 0.9989

ETF Chart for XBI

No chart data available.
  • XBI:US 219.4100
  • 1D
  • 1M
  • 1Y
214.3600
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-03-27) 219.3890
Assets (M) (on 2015-03-27) 2,150.0120
Shares out (M) 9.80
Market Cap (M) 2,150.22
% Premium 0.01
Average 52-Week % Premium -0.0038
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2454
Dividend Yield (ttm) 0.87%

Performance for XBI

1-Month +2.33% 1-Year +55.29%
3-Month +17.56% 3-Year +40.99%
Year To Date +17.79% 5-Year +29.86%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 03/27/2015
Name Position Value % of Total
Prothena Corp PLC 793,573 30,028,802 1.396%
Esperion Therapeutics Inc 305,925 27,732,101 1.289%
Amicus Therapeutics Inc 2,459,804 26,959,452 1.253%
Inovio Pharmaceuticals Inc 3,232,011 26,777,211 1.245%
Alder Biopharmaceuticals Inc 897,575 25,518,057 1.186%
MiMedx Group Inc 2,312,374 24,696,154 1.148%
Orexigen Therapeutics Inc 3,232,031 24,369,514 1.133%
United Therapeutics Corp 139,389 24,108,721 1.121%
Karyopharm Therapeutics Inc 810,338 24,099,452 1.120%
Regeneron Pharmaceuticals Inc 52,959 24,069,866 1.119%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil